Literature DB >> 8530680

Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients.

C Simón1, F Cano, D Valbuena, J Remohí, A Pellicer.   

Abstract

This study was undertaken to investigate an empirical observation that 'high responder patients have poorer in-vitro fertilization (IVF) outcome than normal responder patients'. The aim of our study was to analyse the effect of high serum oestradiol and progesterone concentrations at the day of human chorionic gonadotrophin (HCG) administration on endometrial receptivity and oocyte-embryo quality in high and normal responder patients. The IVF patients were divided into two groups: 59 high responder patients who voluntarily donated some of their oocytes, and a control group consisting of 105 normal responder patients. Both groups were compared in terms of the number and quality of oocytes retrieved, embryos transferred, fertilization, implantation and gestation rates, serum oestradiol and progesterone concentrations and the oestradiol:progesterone ratio on the day of HCG injection. To ascertain oocyte-embryo quality, a second control group of 96 women undergoing oocyte donation (receiving oocytes from high responder patients) was considered. To assess the impact of steroid concentrations on endometrial receptivity, high responder patients were divided into two subgroups according to oestradiol concentration, above or below the minimal oestradiol and progesterone concentrations (mean--SD) in this group. The normal responder patients were divided into two subgroups according to oestradiol concentration, above or below the maximal oestradiol and progesterone concentrations (mean+SD) in this group. To assess further the relevance of oestradiol concentration on endometrial receptivity, patients were divided into different subgroups according to increasing oestradiol concentration, regardless of whether they were high or normal responders. High responder patients had significantly decreased implantation and pregnancy rates per cycle compared with normal responder patients (33.3 versus 16.3 and 11.1 versus 5.4% respectively; P < 0.05). The results of 108 embryo transfers in 91 recipients who received oocytes from the high responder group showed normal embryo quality. Implantation rates and pregnancies per cycle were significantly lower in high responder patients with serum oestradiol concentrations > 1700 pg/ml compared with those having oestradiol concentrations < or = 1700 pg/ml, as well as in normal responder patients with serum oestradiol concentrations > 2200 pg/ml compared with those having oestradiol concentrations < or = 2200 pg/ml. Considering all the patients together, significant decreases in pregnancy and implantation rates were observed when oestradiol concentrations were > 2500 pg/ml compared with patients having lower oestradiol concentrations. Our clinical results demonstrate that high serum oestradiol concentrations on the day of HCG injection in high and normal responder patients, regardless of the number of oocytes retrieved and the serum progesterone concentration, are detrimental to uterine receptivity without affecting embryo quality.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530680     DOI: 10.1093/oxfordjournals.humrep.a136313

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  76 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation.

Authors:  Murat Arslan; Silvina Bocca; Ebru Ozturk Arslan; Hakan E Duran; Laurel Stadtmauer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2007-02-16       Impact factor: 3.412

Review 3.  GnRH agonist for triggering final oocyte maturation in patients at risk of ovarian hyperstimulation syndrome: still a controversy?

Authors:  S Kol; I Solt
Journal:  J Assist Reprod Genet       Date:  2008-02-07       Impact factor: 3.412

4.  The effect of age on in vitro fertilization outcome: is too young possible?

Authors:  Zohreh Nazemian; Navid Esfandiari; Murid Javed; Robert F Casper
Journal:  J Assist Reprod Genet       Date:  2010-11-02       Impact factor: 3.412

5.  GnRH antagonists may affect endometrial receptivity.

Authors:  Beth W Rackow; Harvey J Kliman; Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-04-14       Impact factor: 7.329

Review 6.  Treatment of polycystic ovary patients undergoing IVF.

Authors:  P N Barri; B Coroleu; F Martinez; J M Traver; A Veiga; G Calderon
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

7.  Serum estradiol as a predictor of success of in vitro fertilization.

Authors:  Suneeta Mittal; Prerna Gupta; Neena Malhotra; Neeta Singh
Journal:  J Obstet Gynaecol India       Date:  2013-11-01

8.  Impact of serum estradiol levels on the implantation rate of cleavage stage cryopreserved-thawed embryos transferred in programmed cycles with exogenous hormonal replacement.

Authors:  Silvina Bocca; Elvira Bondía Real; Susanna Lynch; Laurel Stadtmauer; Hind Beydoun; Jacob Mayer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2015-01-07       Impact factor: 3.412

9.  Effect of estradiol on oocyte development.

Authors:  Katherine Bianco; Neal G Mahutte; Aydin Arici; Denny Sakkas; Hugh S Taylor
Journal:  Int J Gynaecol Obstet       Date:  2008-12-03       Impact factor: 3.561

10.  Comprehensive assessment of serum estradiol impact on selected physiologic markers observed during in-vitro fertilization and embryo transfer cycles.

Authors:  Grace Wing Shan Kong; Lai Ping Cheung; Christopher John Haines; Po Mui Lam
Journal:  J Exp Clin Assist Reprod       Date:  2009-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.